Allele and genotype frequencies of CYP2C9 in a Korean population. - Wikidata - wikimedia - TriplyDB

Allele and genotype frequencies of CYP2C9 in a Korean population.

Allele and genotype frequencies of CYP2C9 in a Korean population.

http://www.wikidata.org/entity/Q35826938

about

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects Distal effect of amino acid substitutions in CYP2C9 polymorphic variants causes differences in interatomic interactions against (S)-warfarin Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians In vitro functional characterization of 37 CYP2C9 allelic isoforms found in Chinese Han population.Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population.Cytochrome P450 2C9 (CYP2C9) polymorphisms in Chinese Li population.CYP2C9 Mutation Affecting the Individual Variability of Warfarin Dose Requirement.Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms.Cytochrome P450 pharmacogenetics in African populations: implications for public health.Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes.Quality of Anticoagulation with Warfarin in Korean Patients with Atrial Fibrillation and Prior Stroke: A Multicenter Retrospective Observational Study.DNA sensors to assess the effect of VKORC1 and CYP2C9 gene polymorphisms on warfarin dose requirement in Chinese patients with atrial fibrillation.Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics.CYP1A1m1 and CYP2C9*2 and *3 polymorphism and risk to develop ARV-associated hepatotoxicity and its severity.Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.Evaluation of pharmacokinetic drug interactions between gemigliptin (dipeptidylpeptidase-4 inhibitor) and glimepiride (sulfonylurea) in healthy volunteers Effects of CYP2C9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam.Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups.Population pharmacokinetic analysis of glimepiride with CYP2C9 genetic polymorphism in healthy Korean subjects.Effects of the CYP2C9*13 allele on the pharmacokinetics of losartan in healthy male subjects.Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite.Altered tolbutamide pharmacokinetics by a decrease in hepatic expression of CYP2C6/11 in rats pretreated with 5-fluorouracil.Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of zafirlukast.NAT2, CYP2C9, CYP2C19, and CYP2E1 genetic polymorphisms in anti-TB drug-induced maculopapular eruption.Effects of CYP2C9*1/*3 genotype on the pharmacokinetics of flurbiprofen in Korean subjects.Pharmacogenetic distribution of warfarin and its clinical significance in Korean patients during initial anticoagulation therapy Distribution of CYP2C9*13 allele in the Chinese Han and the long-range haplotype containing CYP2C9*13 and CYP2C19*2

P2860

Q24564755-7162389D-6618-4751-A4D2-33797F2FC2B3 Q28536483-EEF342C2-619C-4ED3-B93F-FF711FAE63E8 Q31016306-6205D2BA-786A-4BF9-9982-8DF0D16FADBD Q33551882-0E412B56-061B-4C95-BEFE-216A03CF6ED4 Q35110430-5B88E1F7-AB84-46C5-B0C9-866FAD0AA2EB Q36492939-22635D64-A8E6-4B52-A0C9-7543C9462374 Q36536698-0408C62C-4F3E-4C2A-827E-0128E61243EF Q36707903-84944A23-C3A2-47AA-944C-6F0B5627751D Q38078754-6CC44488-614B-454B-B673-6B136BBCD1D9 Q38192688-F4F702E8-E2AB-4388-B035-908D5D0D9ABB Q38643436-BD52E14B-53CC-4EC5-9D4C-15A58ACF1496 Q38658281-A214460F-0839-41B5-B16C-D36385645E71 Q39022910-94098124-6B36-40B1-91E2-EDEC0570E21A Q39232150-296E4AA7-8B23-4732-9BC5-85D6F912BF23 Q40267083-975DB248-2742-4F13-9E21-84A71B62AB78 Q40480835-8919FB20-27E0-46A4-AB73-4A3FF12DED98 Q41958385-846E9AD4-EA60-4C0E-95CE-144E7A246B84 Q42018917-437D7590-D350-4627-AE19-C99C263F766A Q42253522-1EF5B916-FF38-4362-B2EC-CC62EE64707B Q44881633-5881BF50-C32C-4A3C-B4BA-DBBB131EA388 Q45928715-98102EAF-FC9D-4C56-A5A4-5BEAD130E2C1 Q51058603-A44117B2-DAC5-4E24-8E4A-BDD20B88DA2D Q51218938-151C3BCF-6499-4278-AA36-B9FCD7482BDB Q51663926-0E05727A-84FA-4E09-845D-FF2311F999A7 Q53455058-4C41038D-634A-4BCD-9D88-38631241E21D Q54172975-B36E3EA2-FA01-4507-9420-F12F4900B739 Q57226195-975ED3D5-72D2-419C-B12E-B3BAC14CA602 Q58491989-AC5CA39D-9CAB-4399-AD58-01EC604C3A12

P2860

Allele and genotype frequencies of CYP2C9 in a Korean population.

http://www.wikidata.org/entity/Q35826938

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Allele and genotype frequencies of CYP2C9 in a Korean population.

@ast

Allele and genotype frequencies of CYP2C9 in a Korean population.

@en

type

label

Allele and genotype frequencies of CYP2C9 in a Korean population.

@ast

Allele and genotype frequencies of CYP2C9 in a Korean population.

@en

prefLabel

Allele and genotype frequencies of CYP2C9 in a Korean population.

@ast

Allele and genotype frequencies of CYP2C9 in a Korean population.

@en

P1433

Q35826938-C5EBE05B-4C20-4CAC-B8B2-0A213552C020

P1476

Q35826938-1F50EB7F-3B0A-4C75-BEDA-073FD3E5126F

P2093

Q35826938-037D2AD2-8D0A-4AFA-A29F-F912CA5C53D5

Q35826938-21DB342F-E566-4F04-8881-2CC49F63D607

Q35826938-319A318B-25EC-47C9-B18C-0C9F75476017

Q35826938-5065386F-56E9-4E88-97E8-F83FD164E6B7

Q35826938-5F9091CC-F9C3-4771-A06F-282FE6824013

Q35826938-7E7F561C-1076-4C33-A31C-E7209B73E098

Q35826938-C16D2462-19BC-484F-BB3B-2F2CFE7B5883

Q35826938-E615D6E8-F470-4BC7-8E11-81093916B77D

P2860

Q35826938-1783601E-C2D3-4C1A-8A70-08B9C1E8991B

Q35826938-1AF3CB7C-B1A4-4A7F-A9E5-DEE8AC97583A

Q35826938-1DFDC7C0-9DBD-4F63-BC77-7F6414AE31CE

Q35826938-1E9EF821-3C0F-4EEB-BD7B-865A00868157

Q35826938-29BAA5B9-428F-4142-89FB-019056488DC2

Q35826938-5ED9722A-5E91-4A29-A196-291E1D501D03

Q35826938-68341EF2-C9C5-421C-817F-112028ECCAF8

Q35826938-6B26DE8B-023F-4FF1-A8F9-44E4788CE968

Q35826938-6DD3D3A4-CED4-46A3-9C07-5E7EC6F192E9

Q35826938-78CA5714-BF9C-4A66-AD89-294A5A63514A

P304

Q35826938-26180755-50C0-48D9-BD9E-CD20A6A85C23

P31

Q35826938-04BF13A3-9D49-4C92-925A-204C4D89EC0F

P356

Q35826938-5D8B5CC3-E946-4471-8C9F-97603BE1DDFC

P407

Q35826938-3CEB0127-829A-4FB0-9DB7-8EC3AD123F91

P433

Q35826938-DA831ADE-8268-41D2-A843-1BF36A61C6ED

P478

Q35826938-566267D8-4479-4811-98FB-2AB4B182C251

P577

Q35826938-90C927D5-53F9-4C65-A2F0-EA4CA134F419

P5875

Q35826938-3A0204A9-9721-437C-9637-4D6F04781BE8

P698

Q35826938-C2C309EC-6B38-495F-8BC4-82282B348431

P932

Q35826938-83B97C86-75C9-4304-A67A-447110D531ED

P356

J.1365-2125.2005.02448.X

P1433

British Journal of Clinical Pharmacology

P1476

Allele and genotype frequencies of CYP2C9 in a Korean population.

@en

P2093

Choon-Gon Jang

http://www.w3.org/2001/XMLSchema#string

Hyun-Kyung Kim

http://www.w3.org/2001/XMLSchema#string

Ji-Hong Kim

http://www.w3.org/2001/XMLSchema#string

Jung-Woo Bae

http://www.w3.org/2001/XMLSchema#string

Mi-Jeong Kim

http://www.w3.org/2001/XMLSchema#string

Sang-In Yang

http://www.w3.org/2001/XMLSchema#string

Seok-Yong Lee

http://www.w3.org/2001/XMLSchema#string

Young-Seo Park

http://www.w3.org/2001/XMLSchema#string

P2860

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism.

Clinical relevance of genetic polymorphisms in the human CYP2C9 gene.

Frequency of cytochrome P450 2C9 mutant alleles in a Korean population

Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.

The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics.

Analysis of CYP2C9*5 in Caucasian, Oriental and black-African populations.

Identification of a novel variant CYP2C9 allele in Chinese.

P304

418-422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.2005.02448.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7576445

http://www.w3.org/2001/XMLSchema#string

P698

16187974

http://www.w3.org/2001/XMLSchema#string

P932

1884827

http://www.w3.org/2001/XMLSchema#string